The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Recurrent Implantation Failure Panels Market Compare Between 2026 And 2030?
The recurrent implantation failure panels market has experienced significant growth over recent years. Its value is anticipated to increase from $0.82 billion in 2025 to $0.9 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 9.5%. This historical expansion can be attributed to factors like rising infertility awareness, the adoption of conventional IVF protocols, the proliferation of diagnostic laboratories, the increasing application of genetic testing, and the demand for endometrial evaluation.
The recurrent implantation failure panels market is anticipated to experience robust expansion over the coming years. By 2030, its size is projected to reach $1.31 billion, demonstrating a compound annual growth rate (CAGR) of 9.8%. This projected increase during the forecast period stems from factors such as the incorporation of AI and machine learning, the proliferation of fertility clinics, the uptake of multi-omics strategies, the creation of automated testing platforms, and a rising patient need for customized fertility remedies. Key developments anticipated in this period encompass personalized implantation risk evaluations, the integration of multi-omics information, AI-driven predictive fertility modeling, continuous monitoring of endometrial receptivity, and heightened automation in genetic and immunological examinations.
Access Your Free Sample Report For In-Depth Market Analysis:
What Key Factors Are Shaping The Recurrent Implantation Failure Panels Market Landscape?
The increasing global incidence of infertility is anticipated to propel the growth of the recurrent implantation failure (RIF) panels market during the projected period. Infertility is defined as the inability to achieve conception after 12 months of regular, unprotected intercourse. Elevated infertility rates are largely attributed to factors such as delaying parenthood, changes in lifestyle, and age-related reductions in reproductive potential, which heighten the probability of conception challenges and unsuccessful assisted reproductive outcomes. Recurrent implantation failure panels assist in infertility management by pinpointing genetic, immunological, and hormonal elements that could obstruct successful embryo implantation, thereby allowing clinicians to develop more individualized treatment approaches and improve in vitro fertilization (IVF) success rates. For instance, in June 2025, information from the Human Fertilisation and Embryology Authority (HFEA), a UK-based statutory regulator of fertility treatment, indicated that roughly 52,400 patients completed more than 77,500 IVF cycles at accredited fertility clinics in 2023. Therefore, the expanding worldwide prevalence of infertility is a key driver for the recurrent implantation failure panels market.
What Segment Categories Shape The Recurrent Implantation Failure Panels Market Segment Landscape?
The recurrent implantation failure panels market covered in this report is segmented –
1) By Product Type: Genetic Panels, Immunological Panels, Endometrial Receptivity Panels, Combined Panels, Other Product Types
2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Microarray, Immunoassay, Other Technologies
3) By Sample Type: Blood, Tissue, Other Sample Types
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Fertility Centers, Other End Users
Subsegments:
1) By Genetic Panels: Chromosomal Abnormality Panels, Gene Mutation Panels, Single Nucleotide Variation Panels, Epigenetic Marker Panels
2) By Immunological Panels: Cytokine Profile Panels, Autoantibody Detection Panels, Natural Killer Cell Activity Panels, T Cell Subset Panels
3) By Endometrial Receptivity Panels: Gene Expression Profiling Panels, Protein Marker Panels, Microbiome Analysis Panels, Histological Assessment Panels
4) By Combined Panels: Genetic And Immunological Panels, Genetic And Endometrial Panels, Immunological And Endometrial Panels, Multi Parameter Comprehensive Panels
5) By Other Product Types: Hormonal Assay Panels, Metabolic Function Panels, Inflammatory Marker Panels, Customized Research Panels
Who Are The Companies Operating Across The Recurrent Implantation Failure Panels Market Value Chain?
Major companies operating in the recurrent implantation failure panels market are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Illumina Inc., Natera Inc., Redcliffe Labs, MedGenome Labs Ltd., Mayo Clinic Laboratories, Fulgent Genetics Inc., LifeCell International, Kindbody Genetics, MapmyGenome, DNA Labs India, Shree IVF Clinic, Inti Labs, Vida Fertility Genetics, Cleveland Clinic, ReceptivaDx (CicloMed), MatriceLab, Reproductive Genetic Innovations (RGI), BGI Genomics Co. Ltd., Embryolab Next Gen IVF, Aksigen IVF, Progenesis IVF, Vani IVF.
Get The Full Recurrent Implantation Failure Panels Market Report:
Which Region Is The Largest In The Recurrent Implantation Failure Panels Market?
North America was the largest region in the recurrent implantation failure panels market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the recurrent implantation failure panels market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Recurrent Implantation Failure Panels Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Recurrent Implantation Failure Panels Market 2026, By The Business Research Company
connected health personal medical devices market report 2026
contract sterilization market report 2026
https://www.thebusinessresearchcompany.com/report/contract-sterilization-global-market-report
orthotic insole 3-d printer market report 2026
https://www.thebusinessresearchcompany.com/report/orthotic-insole-3-d-printer-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model